Intro

This chapter examines the intricacies of the U.S. healthcare system with a particular focus on end-stage renal disease and dialysis treatments. It highlights the rising number of patients, the financial impact on Medicare, and critiques the dialysis industry's shortcomings in prioritizing patient welfare over profits.